MonTa Biosciences is attending the BioEurope conference in Hamburg to meet with biotech and pharma companies [...]
MonTa Biosciences is attending the cancer immunotherapy SITC conference in Washington DC to present data on our [...]
MonTa Biosciences attends the ESMO conference in Barcelona to meet with Key Opinion Leaders to [...]
MonTa Biosciences is invited to a fireside interview at the IP-FAIR conference in Copenhagen on May 8. [...]
MonTa Biosciences join the pharma business conference BioEurope in Vienna to meet with pharma and biotech [...]
MonTa Biosciences closes investment with Consolidated Holdings to secure future development towards clinical trials. Link [...]
MonTa Biosciences is invited to speak and join panel discussion with major Big Pharma companies Roche [...]
MonTa Biosciences attend Bio in Boston from June 4-7th to meet and discuss partnership, collaborations and investment opportunities. Send [...]
MonTa Biosciences attend the AngloNordic Life science conference in London on Mya 24th to meet investors and network [...]
MonTa Biosciences attend the Biotechandmoney conference in London on February 5-6. [...]
MonTa Biosciences attends the BioEurope partnering conference in Berlin from November 4-8. Please book a meeting with [...]
MonTa Biosciences announces completion of license agreements with UC San Diego and Danish Technical University. The immune [...]
MonTa Biosciences attends the Nordic Life Science Days in Malmö to meet with investors and pharma partners. [...]
MonTa Biosciences recruits PhD, Esper Boel former SVP in Novo Nordisk and strategic adviosor in immunotherapy to its Board [...]
MonTa Biosciences attends BioEurope Spring in Barcelona to have meetings with more than 10 of the top [...]
MonTa Biosciences closes an investment from Pre-Seed Innovation to reach key milestones for our cancer [...]
MonTa Biosciences join the NOME Mentoring programme in the North Carolina Research Triangle and are appointed top [...]
MonTa Biosciences awarded to be included in the NOME Nordic Mentoring Network for Entrepreneurship. MonTa Biosciences is priviledged to be part [...]
A news article was published by the Danish Biotech media; Medwatch on the newly granted [...]
MonTa Biosciences is part of the XVac “Grand Solutions” granted an Investment from “Innovationsfonden”. The XVac project [...]